Valeant Confirms Salix Is Up For Sale
Valeant Pharmaceuticals International Inc. on Tuesday confirmed that it's looking to sell several of its assets, including gastrointestinal drugmaker Salix Pharmaceuticals Ltd., which it bought in 2015 for about $14.5 billion....To view the full article, register now.
Already a subscriber? Click here to view full article